Association between acute phase reactants, interleukin-6, tumor necrosis factor-α, and disease activity in Takayasu's arteritis patients

被引:15
作者
Li, Jing [1 ,2 ]
Wang, Yahong [3 ,4 ]
Wang, Yanhong [5 ]
Wang, Ying [3 ,4 ]
Yang, Yunjiao [1 ,2 ]
Zhao, Jiuliang [1 ,2 ]
Li, Mengtao [1 ,2 ]
Tian, Xinping [1 ,2 ]
Zeng, Xiaofeng [1 ,2 ]
机构
[1] Peking Union Med Coll, Dept Rheumatol, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China
[2] Chinese Acad Med Sci, Natl Clin Res Ctr Dermatol & Immunol Dis NCRC DID, Key Lab Rheumatol & Clin Immunol, Minist Educ, Beijing 100730, Peoples R China
[3] Peking Union Med Coll, Dept Ultrasound Imaging, Peking Union Med Coll Hosp, Beijing, Peoples R China
[4] Chinese Acad Med Sci, Beijing, Peoples R China
[5] Chinese Acad Med Sci, Inst Basic Med Sci, Sch Basic Med, Peking Union Med Coll,Dept Epidemiol & Biostat, Beijing, Peoples R China
关键词
Takayasu arteritis; Angiographic examination; Disease activity; Acute phase reactants; Interleukin-6; Tumor necrosis factor-α RHEUMATOLOGY; 1990; CRITERIA; CLASSIFICATION; BIOMARKERS; DIAGNOSIS; PROFILES;
D O I
10.1186/s13075-020-02365-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background To investigate the association between blood biomarkers and disease activity of Takayasu's arteritis (TAK) in a follow-up cohort. Methods Disease activity was assessed by clinical manifestations and repeated vascular Doppler examinations. The association between erythrocyte sedimentation rate (ESR), serum levels of high-sensitive C-reactive protein (hsCRP), interleukin-6(IL-6), and tumor necrosis factor-alpha (TNF alpha) and disease activity were analyzed by logistic regression and survival analysis. Kaplan-Meier method was used to estimate the cumulative remission rate curve, log-rank tests for group comparison, and Cox regression for estimating hazard ratios of these parameters for disease activity. Results 428 patients were included. 188 patients were in active disease, and 240 patients were in inactive disease at baseline. Elevation of ESR, hsCRP, and IL-6 were associated with active disease at baseline and during follow-up. Cox regression and Kaplan-Meier analysis showed that lower possibility and longer time to remission were associated with elevated ESR (hazard ratio [HR] = 0.32, 80 vs 33 weeks, p < 0.001), hsCRP (HR = 0.45, 70 vs 31 weeks, p < 0.001), and IL-6 (HR = 0.54, 66 vs 34 weeks, p < 0.01) in patients with active disease at baseline, while higher risk and shorter time for relapse were associated with elevated ESR (HR = 2.1, 59 vs 111 weeks, p < 0.001), hsCRP (HR = 2.1, 79 vs 113 weeks, p < 0.001), IL-6 (HR = 2.5, 64 vs 117 weeks, p < 0.001), and TNF alpha (HR = 2.7, 65 vs 114 weeks, p < 0.001) in patients with inactive disease at baseline. Conclusions Elevated ESR, CRP, and IL-6 are associated with active disease, lower possibility, and longer time to achieve disease remission. Elevation of any among ESR, CRP, IL-6, and TNF alpha is associated with high risk and short time for relapse during follow-up.
引用
收藏
页数:10
相关论文
共 17 条
  • [1] AREND WP, 1990, ARTHRITIS RHEUM, V33, P1129
  • [2] Pathogenesis of primary large vessel arteritides
    Arnaud, L.
    Haroche, J.
    Duhaut, P.
    Piette, J-C
    Amoura, Z.
    [J]. REVUE DE MEDECINE INTERNE, 2009, 30 (07): : 578 - 584
  • [3] Assessment of disease activity and progression in Takayasu's arteritis with Disease Extent Index-Takayasu
    Aydin, Sibel Z.
    Yilmaz, Neslihan
    Akar, Servet
    Aksu, Kenan
    Kamali, Sevil
    Yucel, Eftal
    Karadag, Omer
    Bicakcigil, Muge
    Ozer, Huseyin
    Kiraz, Sedat
    Onen, Fatos
    Inanc, Murat
    Keser, Gokhan
    Akkoc, Nurullah
    Direskeneli, Haner
    [J]. RHEUMATOLOGY, 2010, 49 (10) : 1889 - 1893
  • [4] Long-Term Outcomes and Prognostic Factors of Complications in Takayasu Arteritis A Multicenter Study of 318 Patients
    Comarmond, Cloe
    Biard, Lucie
    Lambert, Marc
    Mekinian, Arsene
    Ferfar, Yasmina
    Kahn, Jean-Emmanuel
    Benhamou, Ygal
    Chiche, Laurent
    Koskas, Fabien
    Cluzel, Philippe
    Hachulla, Eric
    Messas, Emmanuel
    Resche-Rigon, Matthieu
    Cacoub, Patrice
    Mirault, Tristan
    Saadoun, David
    [J]. CIRCULATION, 2017, 136 (12) : 1114 - 1122
  • [5] Direskeneli H, 2011, CLIN EXP RHEUMATOL, V29, pS86
  • [6] FRIES JF, 1990, ARTHRITIS RHEUM, V33, P1135
  • [7] 2018 Update of the EULAR recommendations for the management of large vessel vasculitis
    Hellmich, Bernhard
    Agueda, Ana
    Monti, Sara
    Buttgereit, Frank
    de Boysson, Hubert
    Brouwer, Elisabeth
    Cassie, Rebecca
    Cid, Maria C.
    Dasgupta, Bhaskar
    Dejaco, Christian
    Hatemi, Gulen
    Hollinger, Nicole
    Mahr, Alfred
    Mollan, Susan P.
    Mukhtyar, Chetan
    Ponte, Cristina
    Salvarani, Carlo
    Sivakumar, Rajappa
    Tian, Xinping
    Tomasson, Gunnar
    Turesson, Carl
    Schmidt, Wolfgang
    Villiger, Peter M.
    Watts, Richard
    Young, Chris
    Luqmani, Raashid Ahmed
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (01) : 19 - 30
  • [8] Hotchi M, 1992, Heart Vessels Suppl, V7, P11, DOI 10.1007/BF01744538
  • [9] Diagnosis and Assessment of Takayasu Arteritis by Multiple Biomarkers
    Ishihara, Takashi
    Haraguchi, Go
    Tezuka, Daisuke
    Kamiishi, Tetsuo
    Inagaki, Hiroshi
    Isobe, Mitsuaki
    [J]. CIRCULATION JOURNAL, 2013, 77 (02) : 477 - 483
  • [10] TAKAYASU ARTERITIS
    KERR, GS
    HALLAHAN, CW
    GIORDANO, J
    LEAVITT, RY
    FAUCI, AS
    ROTTEM, M
    HOFFMAN, GS
    [J]. ANNALS OF INTERNAL MEDICINE, 1994, 120 (11) : 919 - 929